Biogened S.A. (WSE:BGD)
Poland · Delayed Price · Currency is PLN 20.80
0.00 (0.00%)
At close: Jul 24, 2026
Biogened Financials Overview
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 114.04 | 114.04 | 110.93 | 95.56 | 79.62 | 65.32 |
Revenue Growth | 2.80% | 2.80% | 16.09% | 20.02% | 21.89% | 35.15% |
Gross Profit Gross Profit Growth | 73.04 | 73.04 | 76.65 | 63.49 | 57.44 | 42.32 |
Operating Income Operating Income Growth | 9.53 | 9.53 | 9.38 | 9.04 | 8.41 | 3.87 |
Net Income Net Income Growth | 4.62 | 4.62 | 5.82 | 5.1 | 3.38 | 1.96 |
Earnings Per Share EPS Growth | 1.88 | 1.88 | 2.37 | 2.08 | 1.38 | 0.80 |
EPS Growth | -20.59% | -20.59% | 14.22% | 50.74% | 72.46% | 57.92% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Poland Poland Growth | 5,569 |
Export Export Growth | 5,742 |
Total Total Growth | 11,311 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 6.32 | 6.32 | 6.07 | 7.51 | 0 | 0 |
Total Debt Total Debt Growth | 21.03 | 21.03 | 22.27 | 17.76 | 19.29 | 17.32 |
Net Cash (Debt) Net Cash Growth | -14.7 | -14.7 | -16.2 | -10.25 | -19.29 | -17.32 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.99 | -5.99 | -6.60 | -4.17 | -7.85 | -7.05 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 12.47 | 12.47 | 4 | 14.87 | 6.01 | 3.14 |
Capital Expenditures CapEx Growth | -7.35 | -7.35 | -5.49 | -7.15 | -9.36 | -1.57 |
Free Cash Flow Free Cash Flow Growth | 5.13 | 5.13 | -1.49 | 7.72 | -3.35 | 1.57 |
Free Cash Flow Growth | - | - | - | - | - | -77.12% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.05% | 64.05% | 69.10% | 66.44% | 72.14% | 64.78% |
Operating Margin | 8.36% | 8.36% | 8.45% | 9.46% | 10.56% | 5.92% |
Pretax Margin | 6.05% | 6.05% | 6.17% | 7.21% | 8.03% | 5.52% |
Profit Margin | 4.05% | 4.05% | 4.48% | 5.33% | 4.25% | 1.90% |
FCF Margin | 4.49% | 4.49% | -1.35% | 8.08% | -4.21% | 2.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.500 | - | 0.500 | 0.500 | 0.400 | - |
Dividend Per Share Growth | 0% | - | 0% | 25.00% | - | - |
Dividend Yield | 2.40% | -2.31% | -2.17% | -2.22% | -2.36% | -2.33% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.50 | 11.48 | 9.70 | 8.67 | 9.23 | 10.77 |
P/FCF Ratio | 14.62 | 10.35 | - | 5.73 | - | 13.42 |
PS Ratio | 0.47 | 0.47 | 0.51 | 0.46 | 0.39 | 0.32 |